Arquivamento definitivo - Art. 33 da LPI
#11.1.1
12/27/2022
RPI 2712
Application data
Number
112020026563Type
Filing
Publication
PCT
GB2019051852 The application was abandoned: examination was not requested within the 36 months following the 06/28/2019 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 12/27/2022. We update with every new RPI gazette, published weekly.
Applicants
ALZECURE PHARMA AB
SE
Inventors
G. N. (pessoa física)
SE
P. F. (pessoa física)
SE
IPC Classification
Priority claims
GB
1810669.0 · 06/28/2018
Abstract
Trata-se de um composto da fórmula I, em que R1, R2, R3, Q1, Q2 e Q3 são conforme definido no presente documento, sendo que esses compostos são úteis no tratamento contra doenças caracterizadas pela sinalização prejudicada de neurotrofinas e/ou outros fatores tróficos, tais como doença de Alzheimer e semelhantes.
Publications in the Brazilian Industrial Property Gazette (RPI).
#11.1.1
12/27/2022
RPI 2712
#11.1
10/11/2022
RPI 2701
#1.3
03/23/2021
RPI 2620
#1.1
01/05/2021
RPI 2609
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.